D. Cascallar

770 citations
3 papers · 575 · 1 hit paper · h-index 3

Impact in

    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
  • Surgery top 10%
    • Bladder and Urothelial Cancer Treatments
    • Urinary and Genital Oncology Studies

Papers in

    • Colorectal Cancer Screening and Detection 1
    • HER2/EGFR in Cancer Research 1
    • Colorectal and Anal Carcinomas 1
    • Bladder and Urothelial Cancer Treatments 1

D. Cascallar

3 papers receiving 568 citations

D. Cascallar's Hit Papers

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial 2021 · 488 citations
4880+1+3Years since publication100200300400

Peers

D. Cascallar
Comparison fields: 5 of 41
  • Oncology 246
  • Surgery 360
  • Pathology and Forensic Medicine 36
  • Immunology 39
  • Pulmonary and Respiratory Medicine 54
Replace Nicklas Pfanzelter with:
Nicklas Pfanzelter United States
Sergey M. Alekseev Russia
D. Castellano Gauna Spain
Liane Rapatoni Brazil
Daniel Kejzman United States
Denis Schallier Belgium
Vladimir Aleksandrovich Shidin Russia
Jamile Almeida Silva Brazil
Thomas Hoefner Germany
Albert Font Pous Spain
D. Cascallar relative to Nicklas Pfanzelter United States Nicklas Pfanzelter's profile →
Citations per field
00.5×1.5×2.2×
Nicklas Pfanzelter · 1×
Citations per year

Countries citing papers authored by D. Cascallar

Since Specialization
Citations

This map shows the geographic impact of D. Cascallar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Cascallar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Cascallar more than expected).

Fields of papers citing papers by D. Cascallar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Cascallar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Cascallar. The network helps show where D. Cascallar may publish in the future.

Co-authors

The 4 scholars most cited alongside D. Cascallar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Cascallar Line = papers co-authored together D. Cascallar links everyone, so they are left out of the graph.

All Works

3 of 3 papers shown
#Work
1
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Hit paper breakdown →
2021488
2 201744
3 200543

About D. Cascallar

D. Cascallar is a scholar working on Oncology, Surgery, Pathology and Forensic Medicine, Insect Science and Renewable Energy, Sustainability and the Environment, having authored 3 papers that have together received 575 indexed citations. Recurring topics across this work include Colorectal Cancer Screening and Detection (1 paper), Genetic factors in colorectal cancer (1 paper), Colorectal and Anal Carcinomas (1 paper), HER2/EGFR in Cancer Research (1 paper) and Bladder and Urothelial Cancer Treatments (1 paper). The work is most often cited by research in Oncology (246 citations), Surgery (360 citations), Pathology and Forensic Medicine (36 citations), Immunology (39 citations) and Pulmonary and Respiratory Medicine (54 citations). D. Cascallar has collaborated with scholars based in Argentina. Frequent co-authors include Marcelo J. Scopinaro, Guillermo Luis Chantada, Ernesto Gil Deza and Felipe Gustavo Gercovich. Their work appears in journals such as The Lancet Oncology, Journal of Pediatric Hematology/Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact